Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Communicable Diseases Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Communicable Diseases Drugsmarket, defines the market attractiveness level of Communicable Diseases Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Communicable Diseases Drugs industry, describes the types of Communicable Diseases Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Communicable Diseases Drugs market and the development prospects and opportunities of Communicable Diseases Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Communicable Diseases Drugs market in Chapter 13.
By Player:
Janssen Pharmaceutical
Gilead
Merck
GSK
BioCryst Pharmaceuticals
Roche
Novartis
Boehringer Ingelheim
By Type:
HIV
Influenza
TB
Malaria
Hepatitis
HPV
By End-User:
Hospital
Clinic
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Communicable Diseases Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Communicable Diseases Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Communicable Diseases Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Communicable Diseases Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Communicable Diseases Drugs Market Analysis and Outlook to 2022
-
7.1 Global Communicable Diseases Drugs Consumption (2017-2022)
-
7.2 United States Communicable Diseases Drugs Consumption (2017-2022)
-
7.3 Europe Communicable Diseases Drugs Consumption (2017-2022)
-
7.4 China Communicable Diseases Drugs Consumption (2017-2022)
-
7.5 Japan Communicable Diseases Drugs Consumption (2017-2022)
-
7.6 India Communicable Diseases Drugs Consumption (2017-2022)
-
7.7 South Korea Communicable Diseases Drugs Consumption (2017-2022)
8 Region and Country-wise Communicable Diseases Drugs Market Analysis and Outlook to 2028
-
8.1 Global Communicable Diseases Drugs Consumption Forecast (2022-2028)
-
8.2 United States Communicable Diseases Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Communicable Diseases Drugs Consumption Forecast (2022-2028)
-
8.4 China Communicable Diseases Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Communicable Diseases Drugs Consumption Forecast (2022-2028)
-
8.6 India Communicable Diseases Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Communicable Diseases Drugs Consumption Forecast (2022-2028)
9 Global Communicable Diseases Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Communicable Diseases Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global HIV Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Influenza Consumption and Growth Rate (2017-2022)
-
9.1.3 Global TB Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Malaria Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Hepatitis Consumption and Growth Rate (2017-2022)
-
9.1.6 Global HPV Consumption and Growth Rate (2017-2022)
-
9.2 Global Communicable Diseases Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Communicable Diseases Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Communicable Diseases Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global HIV Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Influenza Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global TB Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Malaria Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Hepatitis Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global HPV Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Communicable Diseases Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Communicable Diseases Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Communicable Diseases Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Communicable Diseases Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Communicable Diseases Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Communicable Diseases Drugs Market Competitive Analysis
-
14.1 Janssen Pharmaceutical
-
14.1.1 Janssen Pharmaceutical Company Details
-
14.1.2 Janssen Pharmaceutical Communicable Diseases Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Janssen Pharmaceutical Communicable Diseases Drugs Product and Service
-
14.2 Gilead
-
14.2.1 Gilead Company Details
-
14.2.2 Gilead Communicable Diseases Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Gilead Communicable Diseases Drugs Product and Service
-
14.3 Merck
-
14.3.1 Merck Company Details
-
14.3.2 Merck Communicable Diseases Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Merck Communicable Diseases Drugs Product and Service
-
14.4 GSK
-
14.4.1 GSK Company Details
-
14.4.2 GSK Communicable Diseases Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GSK Communicable Diseases Drugs Product and Service
-
14.5 BioCryst Pharmaceuticals
-
14.5.1 BioCryst Pharmaceuticals Company Details
-
14.5.2 BioCryst Pharmaceuticals Communicable Diseases Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 BioCryst Pharmaceuticals Communicable Diseases Drugs Product and Service
-
14.6 Roche
-
14.6.1 Roche Company Details
-
14.6.2 Roche Communicable Diseases Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Roche Communicable Diseases Drugs Product and Service
-
14.7 Novartis
-
14.7.1 Novartis Company Details
-
14.7.2 Novartis Communicable Diseases Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Novartis Communicable Diseases Drugs Product and Service
-
14.8 Boehringer Ingelheim
-
14.8.1 Boehringer Ingelheim Company Details
-
14.8.2 Boehringer Ingelheim Communicable Diseases Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Boehringer Ingelheim Communicable Diseases Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Communicable Diseases Drugs
-
Figure Communicable Diseases Drugs Picture
-
Table Global Communicable Diseases Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Communicable Diseases Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Communicable Diseases Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Communicable Diseases Drugs Consumption by Country (2017-2022)
-
Figure United States Communicable Diseases Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Communicable Diseases Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Communicable Diseases Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Communicable Diseases Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Communicable Diseases Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Communicable Diseases Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Communicable Diseases Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Communicable Diseases Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Communicable Diseases Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Communicable Diseases Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Communicable Diseases Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Communicable Diseases Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Communicable Diseases Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global HIV Consumption and Growth Rate (2017-2022)
-
Figure Global Influenza Consumption and Growth Rate (2017-2022)
-
Figure Global TB Consumption and Growth Rate (2017-2022)
-
Figure Global Malaria Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatitis Consumption and Growth Rate (2017-2022)
-
Figure Global HPV Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global HIV Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Influenza Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global TB Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Malaria Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hepatitis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global HPV Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Communicable Diseases Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Communicable Diseases Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Janssen Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Janssen Pharmaceutical Communicable Diseases Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Pharmaceutical Communicable Diseases Drugs Product and Service
-
Table Gilead (Foundation Year, Company Profile and etc.)
-
Table Gilead Communicable Diseases Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Communicable Diseases Drugs Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Communicable Diseases Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Communicable Diseases Drugs Product and Service
-
Table GSK (Foundation Year, Company Profile and etc.)
-
Table GSK Communicable Diseases Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Communicable Diseases Drugs Product and Service
-
Table BioCryst Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table BioCryst Pharmaceuticals Communicable Diseases Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioCryst Pharmaceuticals Communicable Diseases Drugs Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Communicable Diseases Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Communicable Diseases Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Communicable Diseases Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Communicable Diseases Drugs Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Communicable Diseases Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Communicable Diseases Drugs Product and Service
-
